HIV

GSK's ViiV Healthcare continues cabaret campaign to engage and inspire HIV community
GSK's ViiV Healthcare continues cabaret campaign to engage and inspire HIV community
Fierce Pharma
pharma marketing
GSK
ViiV Healthcare
HIV
Flag link:
How Gilead's and Merck's Surprise Partnership Will Shake Up the HIV Market
How Gilead's and Merck's Surprise Partnership Will Shake Up the HIV Market
Motley Fool
Gilead Sciences
Merck
HIV
drug development
Flag link:
Gilead, Merck combine forces in HIV
Gilead, Merck combine forces in HIV
BioPharma Dive
Gilead Sciences
Merck
HIV
Flag link:
Aelix posts HIV vaccine data ahead of Gilead combo readout
Aelix posts HIV vaccine data ahead of Gilead combo readout
Fierce Biotech
Aelix Therapeutics
HIV
vaccines
Gilead Sciences
Flag link:
Gilead's Biktarvy build its case for long-term use with 4-year data showing lasting HIV suppression
Gilead's Biktarvy build its case for long-term use with 4-year data showing lasting HIV suppression
Endpoints
Gilead Sciences
Biktarvy
HIV
Flag link:
Exclusive: After four decades, one researcher's radical HIV cure finally gets its shot
Exclusive: After four decades, one researcher's radical HIV cure finally gets its shot
Endpoints
Kamel Khalili
HIV
Excision BioTherapeutics
Flag link:
Incyte makes bid to join the checkpoint inhibitor club
Incyte makes bid to join the checkpoint inhibitor club
Pharmaforum
Incyte
FDA
retifanlimab
anal cancer
HIV
HPV
Flag link:
Gilead partners with a cancer biotech, seeking to develop an HIV immunotherapy
Gilead partners with a cancer biotech, seeking to develop an HIV immunotherapy
BioPharma Dive
Gilead Sciences
HIV
Gritstone Oncology
drug development
Flag link:
FDA Approvals Roundup: Cabenuva, Lupkynis, Verquvo
FDA Approvals Roundup: Cabenuva, Lupkynis, Verquvo
RAPS.org
FDA
Cabenuva
HIV
ViiV
Aurinia
Lupkynis
Merck
Verquvo
Flag link:
3 Blockbuster Drug Launches to Watch This Year
3 Blockbuster Drug Launches to Watch This Year
Motley Fool
drug launches
GSK
Cabenuva
HIV
ViiV
Gilead Sciences
Trodelvy
Eli Lilly
Retevmo
cancer
Flag link:
FDA approves first monthly injectable to treat HIV infection
FDA approves first monthly injectable to treat HIV infection
Stat
ViiV
FDA
Cabenuva
HIV
Flag link:
Fierce Pharma's top 2020 marketing stories pack pandemic punch to digital, reputation and drug launches
Fierce Pharma's top 2020 marketing stories pack pandemic punch to digital, reputation and drug launches
Fierce Pharma
pharma marketing
drug pricing
COVID-19
pandemic
remdesivir
Gilead Sciences
HIV
PrEP
Pfizer
Flag link:
Data sets up 2021 filings for Gilead’s twice-a-year HIV drug lenacapavir
Data sets up 2021 filings for Gilead’s twice-a-year HIV drug lenacapavir
Pharmaforum
Gilead Sciences
lenacapavir
HIV
Flag link:
GSK and ViiV score breakthrough therapy designation in HIV prevention, as Truvada showdown draws nearer
GSK and ViiV score breakthrough therapy designation in HIV prevention, as Truvada showdown draws nearer
Endpoints
GSK
ViiV
FDA
cabotegravir
HIV
PrEP
Flag link:
GSK’s ViiV Healthcare caps virtual HIV summit with a Facebook Live cabaret
GSK’s ViiV Healthcare caps virtual HIV summit with a Facebook Live cabaret
Fierce Pharma
GSK
ViiV
HIV
Facebook
drug marketing
Flag link:
GSK reports its long-acting HIV PrEP tops Gilead's Truvada — again
GSK reports its long-acting HIV PrEP tops Gilead's Truvada — again
Endpoints
GSK
ViiV
cabotegravir
HIV
PrEP
FDA
Flag link:
Gilead announces new data on Biktarvy for the treatment of HIV in Black Americans
Gilead announces new data on Biktarvy for the treatment of HIV in Black Americans
Pharmaceutical Business Review
Gilead Sciences
Biktarvy
HIV
Flag link:
GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen
GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen
Fierce Pharma
GSK
ViiV
Dovato
HIV
Flag link:
Gilead got a boost from a newly approved PrEP drug. Now, a major insurer is dropping coverage
Gilead got a boost from a newly approved PrEP drug. Now, a major insurer is dropping coverage
MedCity News
Gilead Sciences
UnitedHealthcare
PrEP
HIV
Descovy
Truvada
Flag link:
Moderna to open COVID-19 vaccine trials to people with HIV
Moderna to open COVID-19 vaccine trials to people with HIV
Beckers Hospital Review
Moderna Therapeutics
clinical trials
mRNA-1273
vaccines
HIV
Flag link:

Pages